UBS AM’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-46,519
| Closed | -$60.9K | – | 2866 |
|
|
2019
Q1 | $60.9K | Buy |
46,519
+10,318
| +29% | +$13.5K | ﹤0.01% | 2599 |
|
|
2018
Q4 | $33.1K | Sell |
36,201
-5,177
| -13% | -$4.73K | ﹤0.01% | 2603 |
|
|
2018
Q3 | $85.1K | Hold |
41,378
| – | – | ﹤0.01% | 2536 |
|
|
2018
Q2 | $74.6K | Hold |
41,378
| – | – | ﹤0.01% | 2569 |
|
|
2018
Q1 | $97.4K | Buy |
41,378
+28,575
| +223% | +$67.3K | ﹤0.01% | 2460 |
|
|
2017
Q4 | $24.1K | Buy |
+12,803
| New | +$24.1K | ﹤0.01% | 2470 |
|